Tiếng Việt
General description
HPLC cartridge
LiChrospher® CN has polar and hydrophobic properties, thus can be used as less polar alternative to LiChrospher Si 60 in normal phase applications or as less hydrophobic alternative to LiChrospher RP-8 in reversed phase applications. This sorbent is packed into a LiChroCART 125-4 HPLC cartridge. The connection to the HPLC system is being accomplished by use of the manu-CART NT cartrige holder (1.51486).
Application
Development and validation of an HPLC method to determine the stability of fentanyl citrate and bupivacaine hydrochloride mixtures in infusion solutions.: This study developed and validated an HPLC method using LiChrospher® 100 CN for analyzing the stability of fentanyl citrate and bupivacaine hydrochloride in infusion solutions. The method showed high precision and accuracy, making it suitable for routine stability testing in hospital pharmacies (Piekarski et al., 2012).
Analysis Note
Pressure: ≤ 30 bar
Theoretical Plates (N/m) (2-Nitrotoluene): ≥ 40000
Symmetry (2-Nitrotoluene): 0.8 – 1.4
Capacity factor (2-Nitrotoluene): 0.5 – 1.5
Legal Information
LICHROCART is a trademark of Merck KGaA, Darmstadt, Germany
LiChrospher is a registered trademark of Merck KGaA, Darmstadt, Germany
